Molecule intelOpportunity: Strong0

Nortriptyline

8 brands · 4 companies · product forms

1 DRAP alert

Opportunity snapshot

Launch attractiveness
59
Market saturation
11
Price room
100
Regulatory risk
50
8
brands
4
companies
Rs 97.37
median price
7
price points
13.13x
price spread
90
confidence %

Who competes here

Top companies by brand count · leader share 38%

Price room

Across observed sources and strengths
CheapestRs 38
MedianRs 97.37
Most expensiveRs 499
Spread13.13×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 13.13x across 7 trusted points (Rs 38.0-499.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 7 live products for Nortriptyline — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2025-02-18
Recall Alert: Voluntary Recall of 36 Batches of Motival Tablets (Reg # 004539) Manufacture

Why this score

Launch attractiveness

40% supply-gap(32) + 25% price-variation(100) + 20% low-competition(89) + 15% supply-disruption(40), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

4 canonical companies and 8 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 13.13x across 7 trusted points (Rs 38.0-499.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2025-02-18 incl. recall/safety.

Confidence

Reduced by: no ATC code.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.